by Team Small News | Nov 30, 2025 | Natco, Pharma
Natco Pharma, a prominent pharmaceutical company, has recently had its credit rating reaffirmed, accompanied by an enhancement of its credit limits. This development is a testament to the company’s robust financial profile and its ability to maintain a strong... by Team Small News | Nov 15, 2025 | Natco, Pharma
Natco Pharma, a leading Indian pharmaceutical company, has reported a decline in its net profit for the second quarter (Q2) of the current financial year. The company’s net profit stood at Rs 517.9 crore, which represents a decline of 23.44% compared to the same... by Team Small News | Nov 12, 2025 | Cipla, Natco, Pharma
Cipla, Natco, Hetero, and Annora, four prominent Indian pharmaceutical companies, have secured significant contracts to supply generic drugs to China. This development marks a major breakthrough for Indian pharmaceutical companies in the Chinese market. The contracts... by Team Small News | Nov 4, 2025 | Natco, Pharma
The Delhi High Court recently delivered a significant judgment in the case of F. Hoffmann-La Roche Ag & Anr. vs. Natco Pharma, which has far-reaching implications for the pharmaceutical industry. The court’s ruling pertains to the interpretation of Section... by Team Small News | Oct 24, 2025 | Natco, Pharma
NATCO Pharma Limited is an Indian pharmaceutical company that has been facing challenges in maintaining stable cash flow during market downturns. According to recent statistics, the company’s cash flow has been volatile, with significant fluctuations in its... by Team Small News | Oct 20, 2025 | Natco, Pharma
The Supreme Court of India has rejected a plea by Swiss pharmaceutical company F. Hoffmann-La Roche AG (Roche) to restrain Natco Pharma Ltd from selling a generic version of its life-saving spinal muscular atrophy (SMA) drug, Risdiplam, in India. The court upheld a...